AngioScore Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 149

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $230M

AngioScore General Information

Description

Developer of tools for endovascular therapy. The company develops angioplasty catheters for use in the treatment of cardiovascular and vascular disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Corporate Office
  • 5055 Brandin Court
  • Fremont, CA 94538
  • United States
+1 (510) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AngioScore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 30-Jun-2014 $230M 000.00 00000 Completed Generating Revenue
8. Secondary Transaction - Private 24-Jul-2012 00000 000.00 Completed Generating Revenue
7. Secondary Transaction - Private 000.00 Completed
6. Later Stage VC (Series F) 20-Apr-2011 0000 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series E) 09-Oct-2007 0000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 11-Apr-2006 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 19-Jul-2005 00.000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 23-Aug-2004 $15.1M $16.8M 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 28-Mar-2003 $1.63M $1.63M 00.000 Completed Product Development
To view AngioScore’s complete valuation and funding history, request access »

AngioScore Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series D 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series C 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 6,751,590 $0.001000 8% $2.24 $2.24 1x $2.17 15.17%
Series A1 1,632,434 $0.001000 8% $1 $1 1x $1 3.55%
To view AngioScore’s complete cap table history, request access »

AngioScore Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of tools for endovascular therapy. The company develops angioplasty catheters for use in the treatment of card
Therapeutic Devices
Fremont, CA
149 As of 2014
000.00
00000 0000-00-00
000000&0 000.00

000000

ore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
00000000000 0000000
Irvine, CA
000 As of 0000
00000
0000000000.

000000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
00000000000 0000000
Marlborough, MA
00000 As of 0000
00.00
000000000 00 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AngioScore Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Endologix Corporation Irvine, CA 000 00000 0000000000.
Boston Scientific Corporation Marlborough, MA 00000 00.00 000000000 00 00.00
Abiomed Corporate Backed or Acquired Danvers, MA 0000 000.00 000000&0 000.00
Atec Spine Formerly PE-Backed Carlsbad, CA 000 00000 00000000 00000
Apollo Endosurgery Formerly VC-backed Austin, TX 000 00000 000000&0 00000
You’re viewing 5 of 17 competitors. Get the full list »

AngioScore Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AngioScore Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Technology Ventures Venture Capital Minority 000 0000 000000 0
Industry Ventures Venture Capital Minority 000 0000 000000 0
Innomed Ventures Venture Capital Minority 000 0000 000000 0
Jerusalem Global Ventures Venture Capital Minority 000 0000 000000 0
Linkagene Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

AngioScore FAQs

  • When was AngioScore founded?

    AngioScore was founded in 2003.

  • Who is the founder of AngioScore?

    Gary Gershony MD is the founder of AngioScore.

  • Where is AngioScore headquartered?

    AngioScore is headquartered in Fremont, CA.

  • What is the size of AngioScore?

    AngioScore has 149 total employees.

  • What industry is AngioScore in?

    AngioScore’s primary industry is Therapeutic Devices.

  • Is AngioScore a private or public company?

    AngioScore is a Private company.

  • What is the current valuation of AngioScore?

    The current valuation of AngioScore is 00000.

  • What is AngioScore’s current revenue?

    The current revenue for AngioScore is 000000.

  • How much funding has AngioScore raised over time?

    AngioScore has raised $90.9M.

  • Who are AngioScore’s investors?

    California Technology Ventures, Industry Ventures, Innomed Ventures, Jerusalem Global Ventures, and Linkagene are 5 of 10 investors who have invested in AngioScore.

  • Who are AngioScore’s competitors?

    Endologix, Boston Scientific, Abiomed, Atec Spine, and Apollo Endosurgery are some of the 17 competitors of AngioScore.

  • When was AngioScore acquired?

    AngioScore was acquired on 30-Jun-2014.

  • Who acquired AngioScore?

    AngioScore was acquired by The Spectranetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »